Voyager Therapeutics

Voyager Therapeutics is a clinical-stage neurogenetic medicine company developing gene therapies to treat severe neurological disorders. Using proprietary AAV-based delivery platforms and engineered capsids, they design targeted gene delivery and regulation systems to reach the brain and spinal cord. Voyager’s pipeline focuses on neurodegenerative and monogenic CNS diseases (including programs in Parkinson’s and other movement disorders), and they collaborate with academic and industry partners to advance clinical development.